HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial matches breast cancer patients to smarter treatments using tumor markers
Disease control Recruiting nowThis study is for people with metastatic breast cancer (cancer that has spread). It aims to see if choosing treatments based on specific tumor markers (biomarkers) can help control the disease longer. About 700 participants will receive standard therapies matched to their biomark…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:33 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis early-phase study tests an experimental pill, NKT3964, designed to break down a protein (CDK2) that helps cancer cells grow. About 150 adults with advanced or metastatic solid tumors (including ovarian, endometrial, breast, gastric, and lung cancers) that have stopped respon…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New study aims to find best Pre-Surgery hormone treatment for men with breast cancer
Disease control Recruiting nowThis study is for men with hormone receptor-positive breast cancer that has not yet been removed by surgery. It compares different hormone therapy combinations (tamoxifen, anastrozole, degarelix, and abemaciclib) given before surgery to see which works best. The goal is to improv…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Jose Pablo Leone • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
Stress relief program tested for triple negative breast cancer patients
Symptom relief Recruiting nowThis study tests whether a 10-week stress reduction program is doable and helpful for women with early-stage triple negative breast cancer. The program teaches relaxation, coping skills, and problem-solving, and also connects patients with social services for needs like transport…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC